Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02820740 · ClinicalTrials.gov registry record · NA
Feasibility Study on LITT for Medical Refractory Epilepsy
A NA study, sponsored by Monteris Medical.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02820740 is a NA study that was terminated before completion, run by Monteris Medical. The registered enrollment target is 4 participants.
The verdict
NCT02820740, a NA study, was terminated before completion, sponsored by Monteris Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System for the treatment of drug-refractory medial temporal lobe epilepsy in subjects who are candidates for LITT surgery.
Interventions
- DEVICE NeuroBlate System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-04-21 |
| Est. Completion | 2019-06-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02820740
The ClinicalTrials.gov registry entry for NCT02820740 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Monteris Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuroBlate System is the first listed.
NCT02820740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02820740 about?
NCT02820740 is a clinical study titled "Feasibility Study on LITT for Medical Refractory Epilepsy". Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System for the treatment of drug-refractory medial temporal lobe epilepsy in subjects who are candidates for LITT surgery.
What is the current status of trial NCT02820740?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2017-04-21. Estimated completion is 2019-06-24.
What interventions are being tested in trial NCT02820740?
The interventions under investigation include: NeuroBlate System (DEVICE).
Who is sponsoring clinical trial NCT02820740?
This trial is sponsored by Monteris Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.